India, July 13 -- Shares of Freedom Holdings Corp. (FRHC) are falling about 8 percent in Monday morning trading after the company announced the completion of $300 million offering of about 2.4 million... Read More
India, July 13 -- Cadrenal Therapeutics (CVKD), a late-stage biopharmaceutical company, on Monday announced late-breaking data from the Phase 2 study for CAD-1005 in treating Heparin Induced Thrombocy... Read More
India, July 13 -- Q32 Bio Inc. (QTTB) shares surged $9.30, or 83.01 percent, to $20.51 on Monday, after the clinical-stage biotechnology company reported positive 36-week topline results from Part B o... Read More
India, July 13 -- First Hawaiian, Inc. (FHB) shares fell 3.78 percent to $28.99 on Monday after the bank announced an agreement to acquire TriCo Bancshares in an all-stock transaction, a deal that wil... Read More
India, July 13 -- Shares of Braiin Limited (BRAI) are climbing about 57 percent on Monday morning after the company announced the launch of ARIA, the Agentic Real Estate Intelligence and Automation, a... Read More
India, July 13 -- Shares of TriCo Bancshares (TCBK) climbed about 11% on Monday after First Hawaiian, Inc. (FHB) agreed to acquire the regional bank in an all-stock transaction valued at $63.12 per Tr... Read More
India, July 13 -- BioMarin Pharmaceutical Inc. (BMRN) announced that the U.S. FDA has accepted its supplemental New Drug Application (sNDA) for VOXZOGO (vosoritide) to secure full approval for use in ... Read More
India, July 13 -- Following the strength seen over the two previous sessions, stocks have moved back to the downside during trading on Monday. The major averages have all moved lower, with the tech-he... Read More
India, July 13 -- Bavarian Nordic A/S (BVNKF,BAVA.CO), a Danish vaccine company, said on Monday its partner Eurofarma had submitted an application to Brazilian health regulator Anvisa for approval of ... Read More
India, July 13 -- Oncolytics Biotech Inc. (ONCY), a clinical-stage company, provided a clinical and regulatory update on REO 033, the company's study evaluating Pelareorep in combination for the secon... Read More